2m 2m 2m 2m 2m 2m 2m
GENELUX (GNLX)
NASDAQ
$3.01+$0.05 (+1.86%)
Price as of Jun 03, 2026 4:18 PM EDT- $136.8MMarket Cap
- 14.79%1-Year Change
- BiotechnologyIndustry
GENELUX (GNLX)
$3.01+$0.05 (+1.86%)
GNLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.95 | ||
Change | -$0.02 (-0.67%) | ||
Open | $2.97 | ||
High | $3.03 | ||
Low | $2.91 | ||
Previous Close | $2.97 | ||
Volume | 142,710 | ||
30-Day Average Volume | 168,088 | ||
1-Week Change | -1.99% | ||
1-Month Change | 7.66% | ||
1-Year Change | 14.79% | ||
3-Year Change | -89.50% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.8M | ||
Total Assets | $32.4M | ||
Market Cap | $136.8M | ||
Enterprise Value | $127.5M | ||
Period: QTR TTM FY | |||
Revenue | -$14,000.00 | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$8.9M | ||
EBITDA | -$8.9M | ||
Net Working Capital | $19.5M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | -9,106 | ||
P/B | 6 | ||
P/E | -15 | ||
PEG | -1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue